Related Experiment Video
Updated: May 14, 2026

Assessment of Kidney Function in Mouse Models of Glomerular Disease
Published on: June 30, 2018
Alternative pathway dysfunction in kidney disease: a case report and review of dense deposit disease and C3
Amret Hawfield1, Samy S Iskandar, Richard J H Smith
1Wake Forest School of Medicine, Winston-Salem, NC, USA. ahawfiel@wakehealth.edu
Insights
Dysfunction in the alternative pathway of complement activation links dense deposit disease and atypical hemolytic uremic syndrome. Understanding this pathway is key for diagnosing and treating these C3 glomerulopathies.
Area of Science:
- Nephrology
- Immunology
- Pathology
Background:
- Dense deposit disease (DDD), previously membranoproliferative glomerulonephritis type II, is a rare kidney disease.
- It is characterized by the deposition of electron-dense material in the glomerular basement membrane.
- DDD is now understood to be a C3 glomerulopathy, linked to complement alternative pathway dysregulation.
Observation:
- Atypical hemolytic uremic syndrome (aHUS) shares a pathophysiologic link with DDD through complement alternative pathway dysfunction.
- Distinguishing DDD from immune complex-mediated glomerulonephritis is crucial, as DDD shows minimal immunoglobulin deposition.
- Advances in understanding complement dysregulation have refined the classification of DDD.
Findings:
- Alternative complement pathway dysfunction is a unifying factor in DDD and aHUS.
- Immunofluorescence findings, particularly the lack of significant immunoglobulin deposition, help differentiate DDD from other glomerulonephritides.
- The study reviews a case of DDD, highlighting its distinct pathology and clinical course.
Implications:
- Understanding complement alternative pathway dysregulation offers new diagnostic and therapeutic targets for DDD and related C3 glomerulopathies.
- This knowledge helps separate DDD from immune complex glomerulonephritis, improving diagnostic accuracy.
- Further research into complement-mediated kidney diseases is essential for developing effective treatments.
Abstract:
Dysfunction of the alternative pathway of complement activation provides a pathophysiologic link between the C3 glomerulopathies dense deposit disease and glomerulonephritis with C3 deposition and the clinically and histologically distinct atypical hemolytic uremic syndrome. Previously, dense deposit disease was known as membranoproliferative glomerulonephritis type II, but paucity or complete lack of immunoglobulin deposition on immunofluorescence staining and advances in our understanding of alternative pathway dysregulation have separated it from immune complex-mediated membranoproliferative glomerulonephritis types I and III. We discuss a case of dense deposit disease and review the current pathologic classification, clinical course, treatment options, and related conditions.
Related Concept Videos
Chronic Kidney Disease I: Introduction
Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous capillaries...
Chronic Kidney Disease III: Interprofessional Care
Nephrons
Diabetic Nephropathy
Nephrotic Syndrome I : Introduction

